[Antithrombotic therapy for established cerebrovascular disease]

Tidsskr Nor Laegeforen. 2020 Sep 7;140(12). doi: 10.4045/tidsskr.20.0651. Print 2020 Sep 8.
[Article in Norwegian]
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use
  • Atherosclerosis* / drug therapy
  • Cerebrovascular Disorders* / drug therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans

Substances

  • Anticoagulants
  • Fibrinolytic Agents